Analysis Of The Weekly Performance Of InflaRx N.V. (IFRX)

InflaRx N.V. (NASDAQ:IFRX) finished Thursday with an addition of $0.35 to close at $4.00, an upside of 9.59 percent. An average of 600,580 shares of common stock have been traded in the last five days. There was a fall of -$0.10 in the past week, and it reached a new high 5 times over the past 12 months. The last 20 days have seen an average of 264,155 shares traded, while the 50-day average volume stands at 243,226.

IFRX stock has decreased by -3.15% in the last month. The company shares reached their 1-month lowest point of $2.78 on 08/10/23. With the stock rallying to its 52-week high on 04/05/23, shares of the company touched a low of $1.57 and a high of $7.25 in 52 weeks. It has reached a new high 3 times so far this year and achieved 29.03% or $0.90 in price. In spite of this, the price is down -44.83% from the 52-week high.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Valuation Metrics

InflaRx N.V. (IFRX) stock’s beta is 0.99. Other valuation ratios to consider include the price-to-book (PB) ratio at 2.08.

Financial Health

The quick ratio of InflaRx N.V. for the three months ended March 30 was 11.20, and the current ratio was 11.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.01 and a total debt to equity ratio of 0.02 for the quarter ending March 30. Its gross profit as reported stood at $48000.0 compared to revenue of $55.21 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, InflaRx N.V.’s return on assets was -25.60%.

Earnings Surprise

For the three-month period that ended March 30, InflaRx N.V. had $1.6 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$33.02 million in the quarter, while revenues were grew 100.0%. The analyst consensus anticipated InflaRx N.V.’s latest quarter earnings to come in at -$0.3 per share, but it turned out to be -$0.27, a 10.00% surprise. For the quarter, EBITDA amounted to -$19.53 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at InflaRx N.V. (IFRX) price momentum. RSI 9-day as of the close on 10 August was 52.38%, suggesting the stock is Neutral, with historical volatility in this time frame at 75.44%.

As of today, IFRX’s price is $3.70 -2.44% or -$0.10 from its 5-day moving average. IFRX is currently trading -7.62% lower than its 20-day SMA and +140.96% higher than its 100-day SMA. However, the stock’s current price level is -3.61% below the SMA50 and +58.73% above the SMA200.

The stochastic %K and %D were 44.15% and 28.93%, respectively, and the average true range (ATR) was 0.36. With the 14-day stochastic at 81.33% and the average true range at 0.32, the RSI (14) stands at 49.09%. The stock has reached -0.16 on the 9-day MACD Oscillator while the 14-day reading was at -0.22.

Analyst Ratings

Guggenheim upgraded InflaRx N.V. (NASDAQ: IFRX) to a a Buy rating in its most recent analyst report. Previously, the stock was rated as a Neutral. The consensus rating for InflaRx N.V. (IFRX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell IFRX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.

What is IFRX’s price target for the next 12 months?

Analysts predict a range of price targets between $5.45 and $19.06, with a median target of $7.83. Taking a look at these predictions, the average price target given by analysts for InflaRx N.V. (IFRX) stock is $10.04.

Most Popular

Related Posts